Célia Soussi
Célia Soussi a reçu le prix Pierre Fouquet 2026 lors des journées SF2A
Mar 27, 2026 - Cat. Event
Led by Gaël Chételat and Géraldine Rauchs, the Neuropresage research team is dedicated to investigating the pathophysiological mechanisms underlying brain disorders and exploring lifestyle-based interventions. Our multidisciplinary approach combines advanced multimodal neuroimaging, blood biomarker analysis, neuropsychological assessments, sleep evaluations, and non-pharmacological interventions.
Our mission is to deepen our understanding of the mechanisms driving brain diseases, enhance early diagnosis, and develop strategies to prevent, delay, and mitigate their progression.
Our research projects are organized around four key themes :
- Aging & Alzheimer’s disease P.I Gaël Chetelat
- Alcohol-related brain dysfunctionP.I Anne-lise Pitel
- Impact of sleep on brain functionsP.I Géraldine Rauchs
- Schizophrenia & affective disordersP.I Sonia Dollfus / Eric Bui
Si vous avez plus de 18 ans et souhaitez être contacté.e pour recevoir des informations sur notre étude CIRAANO et éventuellement y participer, laissez-nous vos coordonnées dans le formulaire de contact suivant :
Accéder au formulaire
Soutenir notre équipe
Our research topics
Our team
Relevant publications
Men and women show partly distinct effects of physical activity on brain integrity
Gonneaud et al., Alzheimers Dement, 2022
Read on PubmedEffect of an 18-month meditation training on telomeres in older adults. A secondary analysis of the Age-Well randomized controlled trial
Kaliman et al., Sciencedirect, 2024
Read on PubmedCompensation patterns and altered functional connectivity in alcohol use disorder with and without Korsakoff's syndrome
Morand et al., Brain, 2024
Read on PubmedRapid Eye Movement Sleep, Neurodegeneration, and Amyloid Deposition in Aging
André et al., Ann Neurol, 2023
Read on PubmedEffect of an 18-Month Meditation Training on Regional Brain Volume and Perfusion in Older Adults: The Age-Well Randomized Clinical Trial
Chetelat et al., JAMA Neurol., 2022
Read on Pubmed
